Chinese Journal of Antituberculosis ›› 2019, Vol. 41 ›› Issue (7): 765-769.doi: 10.3969/j.issn.1000-6621.2019.07.012
• Original Articles • Previous Articles Next Articles
Duo LI,Fu-zhi ZHANG,Bao-xia CAO,Dai-lun HOU,Ping-xin LYU()
Received:
2019-04-07
Online:
2019-07-10
Published:
2019-07-09
Contact:
Ping-xin LYU
E-mail:Lpx1209@163.com
Duo LI,Fu-zhi ZHANG,Bao-xia CAO,Dai-lun HOU,Ping-xin LYU. Analysis of CT characteristics of multi-drug resistant pulmonary tuberculosis complicated with diabetic mellitus[J]. Chinese Journal of Antituberculosis, 2019, 41(7): 765-769. doi: 10.3969/j.issn.1000-6621.2019.07.012
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2019.07.012
CT征象 | 并发组(60例) | 未并发组(60例) | χ2值 | P值 |
---|---|---|---|---|
小叶或亚段实变 | 56(93.3) | 52(86.7) | 1.48 | 0.224 |
段或叶性实变 | 29(48.3) | 17(28.3) | 5.08 | 0.024 |
大结节 | 16(26.7) | 7(11.7) | 4.36 | 0.037 |
树芽征 | 59(98.3) | 57(95.0) | - | 0.619a |
任何形式空洞 | 56(93.3) | 46(76.7) | 6.54 | 0.011 |
实变内空洞 | 31(51.7) | 24(40.0) | 1.65 | 0.200 |
空洞结节 | 42(70.0) | 34(56.7) | 2.30 | 0.130 |
支气管扩张 | 27(45.0) | 42(70.0) | 7.67 | 0.006 |
钙化 | 11(18.3) | 19(31.7) | 2.84 | 0.092 |
肺叶体积缩小 | 15(25.0) | 9(15.0) | 1.88 | 0.171 |
淋巴结肿大 | 17(28.3) | 18(30.0) | 0.04 | 0.841 |
胸腔积液 | 24(40.0) | 12(20.0) | 5.71 | 0.017 |
CT征象 | 累及肺叶数( | U值 | P值 | |
---|---|---|---|---|
并发组(60例) | 未并发组(60例) | |||
总累及叶数 | 4.72±1.47 | 4.30±1.74 | 1572.00 | 0.212 |
小叶或亚段实变 | 2.60±1.60 | 2.08±1.64 | 1438.00 | 0.053 |
段或叶性实变 | 0.78±0.96 | 0.38±0.72 | 1380.50 | 0.011 |
大结节 | 0.48±0.96 | 0.13±0.39 | 1511.00 | 0.027 |
树芽征 | 3.85±1.64 | 3.52±1.73 | 1642.50 | 0.401 |
任何形式空洞 | 2.05±1.43 | 1.58±1.43 | 1432.00 | 0.046 |
实变内空洞 | 0.98±1.27 | 0.73±1.15 | 1576.00 | 0.196 |
结节空洞 | 1.28±1.30 | 1.00±1.12 | 1579.50 | 0.224 |
支气管扩张 | 0.97±1.37 | 1.58±1.57 | 1335.50 | 0.010 |
钙化 | 0.43±1.16 | 0.55±1.03 | 1576.00 | 0.121 |
肺叶体积缩小 | 0.35±0.68 | 0.25±0.65 | 1635.00 | 0.241 |
[1] | World Health Organization. Global tuberculosis report 2018. Geneva:World Health Organization, 2018. |
[2] |
Wang L, Gao P, Zhang M , et al. Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013. JAMA, 2017,317(24):2515-2523.
doi: 10.1001/jama.2017.7596 URL |
[3] |
Liu Q, Li W, Xue M , et al. Diabetes mellitus and the risk of multidrug resistant tuberculosis: a meta-analysis. Sci Rep, 2017,7(1):1090.
doi: 10.1038/s41598-017-01213-5 URL |
[4] |
Al-Rifai RH, Pearson F, Critchley JA , et al. Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis. PLoS One, 2017,12(11):e0187967.
doi: 10.1371/journal.pone.0187967 URL |
[5] |
Hongguang C, Min L, Shiwen J , et al. Impact of diabetes on clinical presentation and treatment outcome of pulmonary tuberculosis in Beijing. Epidemiol Infect, 2015,143(1):150-156.
doi: 10.1017/S095026881400079X URL |
[6] | 黄华 . 合并糖尿病肺结核的CT影像分析. 中国防痨杂志, 2010,32(7):33-36. |
[7] | 赵雁林, 逢宇 . 结核病实验室检验规程. 北京, 人民卫生出版社, 2015. |
[8] |
Guariguata L, Whiting DR, Hambleton I , et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract, 2014,103(2):137-149.
doi: 10.1016/j.diabres.2013.11.002 URL |
[9] | Yorke E, Atiase Y, Akpalu J , et al. The Bidirectional Relationship between Tuberculosis and Diabetes. Tuberc Res Treat, 2017,2017:1702578. |
[10] |
Wang X, Ma A, Han X , et al. T Cell Profile was Altered in Pulmonary Tuberculosis Patients with Type 2 Diabetes. Med Sci Monit, 2018,24:636-642.
doi: 10.12659/MSM.905651 URL |
[11] | Saktiawati AMI, Subronto YW . Influence of Diabetes Mellitus on the Development of Multi Drug Resistant-Tuberculosis in Yogyakarta. Acta Med Indones, 2018,50(1):11-17. |
[12] |
Perez-Navarro LM, Restrepo BI, Fuentes-Dominguez FJ , et al. The effect size of type 2 diabetes mellitus on tuberculosis drug resistance and adverse treatment outcomes. Tuberculosis (Edinb), 2017,103:83-91.
doi: 10.1016/j.tube.2017.01.006 URL |
[13] |
Pérez-Navarro LM, Fuentes-Dominguez FJ, Zenteno-Cuevas R . Type 2 diabetes mellitus and its influence in the development of multidrug resistance tuberculosis in patients from southeastern Mexico. J Diabetes Complications, 2015,29(1):77-82.
doi: 10.1016/j.jdiacomp.2014.09.007 URL |
[14] |
Mi F, Jiang G, Du J , et al. Is resistance to anti-tuberculosis drugs associated with type 2 diabetes mellitus? A register review in Beijing, China. Glob Health Action, 2014,7:24022.
doi: 10.3402/gha.v7.24022 URL |
[15] |
Tegegne BS, Habtewold TD, Mengesha MM , et al. Association between diabetes mellitus and multi-drug-resistant tuberculosis: a protocol for a systematic review and meta-analysis. Systematic Reviews, 2017,6(1):6.
doi: 10.1186/s13643-017-0407-9 URL |
[16] | 宋瑞娟, 夏露, 卢水华 . 糖尿病与耐药肺结核的关系. 中国防痨杂志, 2017,39(1):11-15. |
[17] |
周新华 . 肺结核的影像学诊断——从形态分析到分子影像诊断. 中国防痨杂志, 2014,36(8):638-642.
doi: 10.3969/j.issn.1000-6621.2014.08.004 URL |
[18] |
Kumar Nathella P, Babu S . Influence of diabetes mellitus on immunity to human tuberculosis. Immunology, 2017,152(1):13-24.
doi: 10.1111/imm.2017.152.issue-1 URL |
[19] | Perez-Guzman C, Torres-Cruz A, Villarreal-Velarde H , et al. Atypical radiological images of pulmonary tuberculosis in 192 diabetic patients: a comparative study. Int J Tuberc Lung Dis, 2001,5(5):455-461. |
[20] |
Chiang CY, Lee JJ, Chien ST , et al. Glycemic control and radiographic manifestations of tuberculosis in diabetic patients. PLoS One, 2014,9(4):e93397.
doi: 10.1371/journal.pone.0093397 URL |
[21] |
Huang LK, Wang HH, Lai YC , et al. The impact of glycemic status on radiological manifestations of pulmonary tuberculosis in diabetic patients. PLoS One, 2017,12(6):e0179750.
doi: 10.1371/journal.pone.0179750 URL |
[22] | 祁志华 . 2型糖尿病并发肺结核的肺部CT特征及与糖化血红蛋白水平关系分析. 中国基层医药, 2018,25(16):2110-2113. |
[23] | 舒伟强, 李春华, 王惠秋 , 等. 2型糖尿病并发肺结核患者血糖水平与CT特征的相关性分析. 中国防痨杂志, 2017,39(6):565-569. |
[24] |
Song Q, Zhang G, Jiang H , et al. Imaging Features of Pulmonary CT in Type 2 Diabetic Patients with Multidrug-Resistant Tuberculosis. PLoS One, 2016,11(3):e0152507.
doi: 10.1371/journal.pone.0152507 URL |
[25] |
Li D, He W, Chen B , et al. Primary multidrug-resistant tuberculosis versus drug-sensitive tuberculosis in non-HIV-infected patients: Comparisons of CT findings. PLoS One, 2017,12(6):e0176354.
doi: 10.1371/journal.pone.0176354 URL |
[26] |
Magee MJ, Kempker RR, Kipiani M , et al. Diabetes mellitus is associated with cavities, smear grade, and multidrug-resis-tant tuberculosis in Georgia. Int J Tuberc Lung Dis, 2015,19(6):685-692.
doi: 10.5588/ijtld.14.0811 URL |
[27] |
Pang L, Wang Y, Zheng M , et al. Transcriptomic study of high-glucose effects on human skin fibroblast cells. Mol Med Rep, 2016,13(3):2627-2634.
doi: 10.3892/mmr.2016.4822 URL |
[1] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[2] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[3] | Li Leilei, Shi Lei, Wang Lin, Li Hongwei, Xu Liran, Pang Yu, Song Yanzheng. Clinical characteristics analysis of HIV-infected cases diagnosed with tuberculosis after surgery due to pulmonary nodules [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 266-273. |
[4] | Zhang Guoqin, Qu Ting, Meng Qinglin, Zhou Lin, Liu Eryong. Implementation update of strategy for the control of tuberculosis and HIV/AIDS co-infection in China [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 12-17. |
[5] | Huang Tao, Jian Huiyong, Wang Xinqi, Liu Nianqiang, Yipar Aihaiti, Wang Mingzhe, Jiayinati Jingesi, Wang Senlu. Analysis of influencing factors of treatment outcomes in patients with pulmonary tuberculosis complicated with diabetes mellitus in Xinjiang Uygur Autonomous Region [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1083-1088. |
[6] | Yang Liangzi, Zhang Peize, Lu Shuihua. Interpretation of World Health Organization’s Co-administration of Treatment for Drug-resistant Tuberculosis and Hepatitis C: 2024 Update [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 874-876. |
[7] | Liu Ling, Zeng Yi, Wang Jin, Liu Xiaoling, Liu Yan, Lin Feishen, Guo Jing. Construction and evaluation of a model for predicting malnutrition in patients with pulmonary tuberculosis and diabetes mellitus [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 903-909. |
[8] | Cai Qinghe, Fu Hui, Chen Ruiming, Fan Youming, Yang Qingwei. Analysis of the clinical characteristics and influencing factors of pulmonary tuberculosis patients with diabetes mellitus in Shantou City from 2016 to 2022 [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 926-934. |
[9] | Jiang Bijia, Chen Cheng, Zhou Jinyi, Zhu Limei, Su Jian, Lu Wei. Analysis of tuberculosis incidence and influencing factors in type 2 diabetic patients in community [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 951-957. |
[10] | Chai Dongyu, Qin Shuyi, Zhang Ronghua, Zou Nannan, Wang Xin. Analysis of risk factors for viral pneumonia combined with invasive pulmonary mycosis [J]. Chinese Journal of Antituberculosis, 2024, 46(7): 750-755. |
[11] | Fu Keyan, Zhu Bangzheng, Ye Jian. Research progress on interstitial lung disease combined with Mycobacterium tuberculosis infection [J]. Chinese Journal of Antituberculosis, 2024, 46(7): 823-829. |
[12] | Liu Guizhen, Deng Guofang. Interpretation of Evidence and research gaps identified during development of policy guidelines for tuberculosis (Second edition): tuberculosis related comorbidity [J]. Chinese Journal of Antituberculosis, 2024, 46(6): 618-624. |
[13] | Li Yao, Fang Zhe, Luo Danlin, Hu Yanmei, Tang Mi, Tang Zhigang, Wen Xinmin, Zhang Yong, Yao Bibo, Wang Qi, Yi Hengzhong. Clinical characteristics and prognosis of patients with novel coronavirus infection complicated with pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(6): 687-698. |
[14] | Yang Rui, Li Ling, Chen Jinou, Xu Lin. Analysis of influencing factors of anti-tuberculosis treatment effect for pulmonary tuberculosis patients complicated with diabetes in Yunnan Province from 2017 to 2021 [J]. Chinese Journal of Antituberculosis, 2024, 46(5): 519-524. |
[15] | Liu Meijun, Li Feng. Current situation and research progress of co-infection of HIV/AIDS and subclinical tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(5): 596-600. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||